Oosterhuis B, Wetsteyn J C, van Boxtel C J
Ther Drug Monit. 1984;6(2):215-20. doi: 10.1097/00007691-198406000-00015.
A sensitive method is described for the simultaneous determination of mebendazole and hydroxymebendazole using flubendazole as an internal standard. The analytes were isolated with a single chloroform extraction from 1.0 ml of alkalinized plasma or cyst liquid samples. Separation and quantitation were performed with high-performance liquid chromatography with electrochemical detection. The limit of detection for mebendazole and hydroxymebendazole was approximately 5 and 2.5 ng/ml, respectively. The accuracy of the method was confirmed for mebendazole by a good correlation with an existing radioimmunoassay method. The method was applied for monitoring mebendazole therapy in echinococcosis patients. The results presented support the necessity of such monitoring, as most of the observed peak plasma concentrations did not reach the level regarded as minimal for therapeutic effect.
本文描述了一种灵敏的方法,该方法以氟苯达唑作为内标,同时测定甲苯咪唑和羟基甲苯咪唑。从1.0 ml碱化血浆或囊液样品中通过单次氯仿萃取分离出分析物。采用高效液相色谱-电化学检测法进行分离和定量。甲苯咪唑和羟基甲苯咪唑的检测限分别约为5 ng/ml和2.5 ng/ml。通过与现有的放射免疫分析法具有良好的相关性,证实了该方法对甲苯咪唑的准确性。该方法用于监测棘球蚴病患者的甲苯咪唑治疗情况。所呈现的结果支持了这种监测的必要性,因为观察到的大多数血浆峰浓度未达到被认为具有治疗效果的最低水平。